Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4.
Collins PJ, McCully ML, Martínez-Muñoz L, Santiago C, Wheeldon J, Caucheteux S, Thelen S, Cecchinato V, Laufer JM, Purvanov V, Monneau YR, Lortat-Jacob H, Legler DF, Uguccioni M, Thelen M, Piguet V, Mellado M, Moser B.
Collins PJ, et al. Among authors: uguccioni m.
FASEB J. 2017 Jul;31(7):3084-3097. doi: 10.1096/fj.201700013R. Epub 2017 Mar 30.
FASEB J. 2017.
PMID: 28360196
Free PMC article.
Our findings provide new insights that will inform the development of novel therapeutics that target CXCR4 in a range of diseases, including cancer, autoimmunity, and HIV.-Collins, P. J., McCully, M. L., Martinez-Munoz, L., Santiago, C., Wheeldon, J., Caucheteux, S., Thele …
Our findings provide new insights that will inform the development of novel therapeutics that target CXCR4 in a range of diseases, including …